| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/10/2011 | WO2010108164A3 Novel anti-parasitic compounds |
| 03/10/2011 | WO2010079511A4 Mammalian colostrum derived nanopeptides for broadspectrum viral and recurrent infections with a method of isolation thereof |
| 03/10/2011 | US20110061114 Novel pro258 gene disruptions, and methods relating thereto |
| 03/10/2011 | US20110060122 Process for preparing glycopeptide phosphonate derivatives |
| 03/10/2011 | US20110060030 Modulation of apolipoprotein c-iii expression |
| 03/10/2011 | US20110059905 Methods of treating disease-induced ataxia and non-ataxic imbalance |
| 03/10/2011 | US20110059904 Serum-based, diagnostic, biological assay to predict pregnancy disorders |
| 03/10/2011 | US20110059903 Formulations Comprising Linaclotide |
| 03/10/2011 | US20110059902 Therapeutic Replenishment and Enrichment of Ocular Surface Lubrication |
| 03/10/2011 | US20110059901 Compositions and Methods for Treatment of Neoplastic Disease |
| 03/10/2011 | US20110059900 Diagnosing and treating hormone resistant cancers |
| 03/10/2011 | US20110059899 Kruppel-like factor 6 (KLF6), a tumor suppressor protein, and diagnostics, therapeutics, and screening based on this protein |
| 03/10/2011 | US20110059898 Pro-oxidant anti-cancer compounds |
| 03/10/2011 | US20110059897 Methods for treating a skin wound |
| 03/10/2011 | US20110059896 Use of furin convertase inhibitors in the treatment of fibrosis and scarring |
| 03/10/2011 | US20110059895 Modulation of factor 9 expression |
| 03/10/2011 | US20110059894 Factor VII Polypeptides for Preventing Formation of Inhibitors in Subjects with Haemophilia |
| 03/10/2011 | US20110059893 Compounds for the treatment of proliferative disorders |
| 03/10/2011 | US20110059892 Cosmetic preparations containing PTH fragments |
| 03/10/2011 | US20110059891 Alpha-msh therapies for treatment of autoimmune disease |
| 03/10/2011 | US20110059890 Expression vectors and cell lines expressing vascular endothelial growth factor d, and method of treating melanomas |
| 03/10/2011 | US20110059889 PEPTIDES THAT BLOCK THE BINDING OF IgG TO FcRn |
| 03/10/2011 | US20110059888 Metastin derivatives and use thereof |
| 03/10/2011 | US20110059887 Meal-time insulin analogues of enhanced stability |
| 03/10/2011 | US20110059886 HCV NS3-NS4A Protease Inhibition |
| 03/10/2011 | US20110059885 Treatment of diseases and conditions mediated by eicosanoids |
| 03/10/2011 | US20110059531 Method for expression of small rna molecules within a cell |
| 03/10/2011 | US20110059522 Nucleic acids encoding a house dust mite allergen, der p iii, and uses thereof |
| 03/10/2011 | US20110059486 Non-splicing variants of gp350/220 |
| 03/10/2011 | US20110059188 Compositions for reducing dental erosion |
| 03/10/2011 | US20110059174 PKCdelta REGULATES NEUROINFLAMMATORY EVENTS |
| 03/10/2011 | US20110059173 encoding a polypeptide comprising a carboxy-terminal amino acid sequence of an alpha Connexin; reduces scar formation |
| 03/10/2011 | US20110059172 Therapeutic compositions |
| 03/10/2011 | US20110059167 Encapsulation of biologically active agents |
| 03/10/2011 | US20110059160 Methods and compositions for targeted gene modification |
| 03/10/2011 | US20110059159 Nanoscale bound bilayers, methods of use and production |
| 03/10/2011 | US20110059147 Long term drug delivery devices with polyurethane based polymers and their manufacture |
| 03/10/2011 | US20110059142 Encapsulation of biologically active agents |
| 03/10/2011 | US20110059140 Extruded rod-shaped devices for controlled release of biological substances to humans and animals |
| 03/10/2011 | US20110059125 Zwitterionic immunomodulators for the treatment of asthma and allergy |
| 03/10/2011 | US20110059120 Glucan-based vaccines |
| 03/10/2011 | US20110059108 Methods of modulating apoptosis by administration of relaxin agonists or antagonists |
| 03/10/2011 | US20110059106 Methods for modulating a population of myeloid-derived suppressor cells and uses thereof |
| 03/10/2011 | US20110059104 Apo-2L receptor agonist and CPT-11 synergism |
| 03/10/2011 | US20110059103 Future cardiac event biomarkers |
| 03/10/2011 | US20110059091 Inhibitors of oncogenic isoforms and uses thereof |
| 03/10/2011 | US20110059089 Protein Markers for Cardiovascular Events |
| 03/10/2011 | US20110059088 Protein involved in ovarian cancer |
| 03/10/2011 | US20110059076 Human serum albumin linkers and conjugates thereof |
| 03/10/2011 | US20110059074 Knowledge-Based Proliferation Signatures and Methods of Use |
| 03/10/2011 | US20110059069 Gapr-1 Methods |
| 03/10/2011 | US20110059068 Polypeptides involved in immune response |
| 03/10/2011 | US20110059067 Modulation of oligonucleotide cpg-mediated immune stimulation by positional modification of nucleosides |
| 03/10/2011 | US20110059065 Function and regulation of adamts-1 |
| 03/10/2011 | US20110059062 Use of hydrolytic and oxidative enzymes to dissolve biofilm in airway passages |
| 03/10/2011 | US20110059061 Bioabsorbable Surgical Composition |
| 03/10/2011 | US20110059060 Thuricin cd, an antimicrobial for specifically targeting clostridium difficile |
| 03/10/2011 | US20110059059 Methods for Treating Ischemic Tissue |
| 03/10/2011 | US20110059056 Method for the Generation of Genetically Modified Vertebrate Precursor Lymphocytes and Use Thereof for the Production of Heterologous Binding Proteins |
| 03/10/2011 | US20110059047 Novel macrocyclic inhibitors of hepatitis c virus replication |
| 03/10/2011 | US20110059046 Derivatives of gefitinib |
| 03/10/2011 | US20110059045 Pharmaceutical composition for cancer treatment |
| 03/10/2011 | US20110059044 Method of treating pulmonary disease with interferons |
| 03/10/2011 | US20110059043 Chemical compounds |
| 03/10/2011 | US20110059042 Substituted il-15 |
| 03/10/2011 | US20110059041 Vaccine for treatment and prevention of herpes simplex virus infection |
| 03/10/2011 | US20110059021 Process for preparing variant of erysipelothrix rhusiopathiae surface protective antigen in e. coli |
| 03/10/2011 | US20110059015 Vaccine |
| 03/10/2011 | US20110059011 Diagnosis and treatment of diseased and damaged tissue |
| 03/10/2011 | CA2773176A1 Treatment of diseases caused by bacterial exotoxins |
| 03/10/2011 | CA2773083A1 Immunity-inducing agent |
| 03/10/2011 | CA2773062A1 A bone regeneration agent comprising gelatin |
| 03/10/2011 | CA2772912A1 Stable formulation of factor viii |
| 03/10/2011 | CA2772742A1 Antibiotic compounds |
| 03/10/2011 | CA2772057A1 Targeted delivery using tissue-specific peptidomimetic ligands |
| 03/10/2011 | CA2772051A1 Coagulation factor ix compositions and methods of making and using same |
| 03/10/2011 | CA2771999A1 Coagulation factor vii compositions and methods of making and using same |
| 03/10/2011 | CA2771900A1 Tumoricidal, bactericidal, or viricidal macrophage activation |
| 03/10/2011 | CA2771770A1 Pcsk9 vaccine |
| 03/10/2011 | CA2769602A1 Modified agrin-fragment capable of restoring muscle strength for use as a medicament |
| 03/09/2011 | EP2293067A2 T1R hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds |
| 03/09/2011 | EP2292772A1 HIV vaccination with a DNA encoding a HIV polypeptide and a HIV polypeptide |
| 03/09/2011 | EP2292771A2 Sense mRNA therapy |
| 03/09/2011 | EP2292770A2 Methods and means for producing proteins with predetermined post-translational modifications |
| 03/09/2011 | EP2292748A1 Method for producing gamma-carboxylated proteins |
| 03/09/2011 | EP2292665A1 Use of interleukin-4 antagonists and compositions thereof |
| 03/09/2011 | EP2292661A2 Interleukin-10 antibodies |
| 03/09/2011 | EP2292658A2 Novel immunoadhesins for treating and preventing toxicity and pathogen-mediated diseases |
| 03/09/2011 | EP2292657A1 Reduced side-effect hemoglobin compositions |
| 03/09/2011 | EP2292656A2 Method for preparing a Von Willebrand concentrate (FvW) by chromatographic means and FvW concentrate that can be thus obtained |
| 03/09/2011 | EP2292655A1 Peptides and related molecules that bind to tall-1 |
| 03/09/2011 | EP2292654A2 A lymphocyte surface receptor that binds CAML, nucleic acids encoding the same and methods of use thereof |
| 03/09/2011 | EP2292653A1 Novel insulin derivatives |
| 03/09/2011 | EP2292652A2 Interferons uses and compositions related thereto |
| 03/09/2011 | EP2292651A1 Methods and compositions for the prevention and treatment of anemia |
| 03/09/2011 | EP2292650A1 Methods and compositions for the prevention and treatment of anemia |
| 03/09/2011 | EP2292649A2 Therapeutic epitopes and uses thereof |
| 03/09/2011 | EP2292642A1 Immunomodulating compositions, uses therefor and processes for their production |
| 03/09/2011 | EP2292641A2 Expression in filamentous fungi of protease inhibitors and variants thereof |
| 03/09/2011 | EP2292640A2 Base-substituted benzylamine analogs for use as coagulation factor Xa inhibitors, the production and use thereof |